DK273489A - Terapeutisk produkt - Google Patents

Terapeutisk produkt Download PDF

Info

Publication number
DK273489A
DK273489A DK273489A DK273489A DK273489A DK 273489 A DK273489 A DK 273489A DK 273489 A DK273489 A DK 273489A DK 273489 A DK273489 A DK 273489A DK 273489 A DK273489 A DK 273489A
Authority
DK
Denmark
Prior art keywords
product
oestrogen
therapeutic product
manufacture
pharmaceutical composition
Prior art date
Application number
DK273489A
Other languages
English (en)
Other versions
DK273489D0 (da
DK175740B1 (da
Inventor
Michael Dukes
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of DK273489D0 publication Critical patent/DK273489D0/da
Publication of DK273489A publication Critical patent/DK273489A/da
Application granted granted Critical
Publication of DK175740B1 publication Critical patent/DK175740B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198902734A 1988-06-06 1989-06-02 Terapeutisk produkt til behandlingen af perimenopausale eller postmenopausale tilstande DK175740B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888813353A GB8813353D0 (en) 1988-06-06 1988-06-06 Therapeutic product
GB8813353 1988-06-06

Publications (3)

Publication Number Publication Date
DK273489D0 DK273489D0 (da) 1989-06-02
DK273489A true DK273489A (da) 1989-12-07
DK175740B1 DK175740B1 (da) 2005-02-07

Family

ID=10638154

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902734A DK175740B1 (da) 1988-06-06 1989-06-02 Terapeutisk produkt til behandlingen af perimenopausale eller postmenopausale tilstande

Country Status (17)

Country Link
US (1) US5183814A (da)
EP (1) EP0346014B1 (da)
JP (1) JP2918042B2 (da)
AT (1) ATE109351T1 (da)
AU (1) AU622184B2 (da)
CA (1) CA1337591C (da)
DE (1) DE68917219T2 (da)
DK (1) DK175740B1 (da)
ES (1) ES2057124T3 (da)
FI (1) FI892762A7 (da)
GB (1) GB8813353D0 (da)
IE (1) IE64368B1 (da)
IL (1) IL90410A (da)
NO (1) NO892293L (da)
NZ (1) NZ229392A (da)
PT (1) PT90764B (da)
ZA (1) ZA893892B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
US5407947A (en) * 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
US5612317A (en) * 1994-08-04 1997-03-18 Holick; Michael F. Method for delivering estrogen
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5965551A (en) * 1996-02-21 1999-10-12 North Carolina State University Method of treating alopecia
DE19807791A1 (de) * 1998-02-19 1999-08-26 Schering Ag Kombinationspräparat aus Östrogen und Antiöstrogen
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
DE10039199A1 (de) * 2000-08-10 2002-02-21 Schering Ag Kombinationspräparate aus einem ERß selektiven Estrogen und einem SERM oder Antiestrogen
EP1287817A1 (en) * 2001-08-31 2003-03-05 Pantarhei Bioscience B.V. Method of treating uterine leiomyomas and intravaginal drug delivery vehicle for use in such method
EP1406662A1 (en) * 2001-07-07 2004-04-14 AstraZeneca AB Pharmaceutical formulation for the intramuscular administration of fulvestrant
GB0116620D0 (en) * 2001-07-07 2001-08-29 Astrazeneca Ab Formulation
CN1599606A (zh) 2001-07-31 2005-03-23 辉瑞产品公司 包含雌激素激动剂/拮抗剂、雌激素与孕激素组合的药物组合物、试剂盒和方法
WO2003017974A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
GB0302572D0 (en) * 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
MXPA05010871A (es) * 2003-04-11 2005-11-25 Barr Lab Inc Metodos para administrar estrogenos y progestinas.
AU2004281551B2 (en) * 2003-10-17 2009-10-29 Intervet International B.V. Compositions for controlling parasites comprising a combination of abamectin and ivermectin
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
SG165404A1 (en) * 2005-09-26 2010-10-28 Hospira Australia Pty Ltd Fulvestrant formulation
DE102005057224A1 (de) 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP2048126A1 (de) 2007-10-11 2009-04-15 Bayer Schering Pharma AG Benzocycloheptanderivate als selektiv wirksame Estrogene
EP2258375A1 (de) 2009-06-04 2010-12-08 Bayer Schering Pharma Aktiengesellschaft 17B-alkyl-17alpha-oxy-estratriene
DE102010030538A1 (de) 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
CA2836831C (en) 2011-05-20 2015-06-02 Capital, Business Y Gestion De Finanzas S.L. Pharmaceutical composition
DE102011087987A1 (de) 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
CN102600073B (zh) * 2012-03-31 2014-01-01 莱普德制药有限公司 以乳酸酯为基础的氟维司群或其衍生物油性制剂及其制备方法
US9271990B2 (en) * 2014-02-14 2016-03-01 Fresenius Kabi Usa, Llc Fulvestrant formulations
RU2684330C1 (ru) * 2018-02-02 2019-04-08 Закрытое Акционерное Общество "Биокад" Композиции фулвестранта

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311678D0 (en) * 1983-04-28 1983-06-02 Ici Plc Phenol derivatives
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency

Also Published As

Publication number Publication date
PT90764A (pt) 1989-12-29
AU622184B2 (en) 1992-04-02
IL90410A (en) 1994-07-31
DK273489D0 (da) 1989-06-02
CA1337591C (en) 1995-11-21
IE64368B1 (en) 1995-07-26
NO892293D0 (no) 1989-06-05
NO892293L (no) 1989-12-07
FI892762L (fi) 1989-12-07
NZ229392A (en) 1992-01-29
ES2057124T3 (es) 1994-10-16
FI892762A7 (fi) 1989-12-07
DK175740B1 (da) 2005-02-07
DE68917219D1 (de) 1994-09-08
JPH0242024A (ja) 1990-02-13
JP2918042B2 (ja) 1999-07-12
GB8813353D0 (en) 1988-07-13
DE68917219T2 (de) 1994-12-15
FI892762A0 (fi) 1989-06-06
IE891670L (en) 1989-12-06
PT90764B (pt) 1994-10-31
ATE109351T1 (de) 1994-08-15
EP0346014A1 (en) 1989-12-13
ZA893892B (en) 1990-02-28
EP0346014B1 (en) 1994-08-03
AU3592389A (en) 1989-12-07
US5183814A (en) 1993-02-02

Similar Documents

Publication Publication Date Title
DK273489D0 (da) Terapeutisk produkt
DE3679908D1 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
FI102591B (fi) Pursotettava, joustava, suun kautta annettava liuoksen muodossa oleva geelikoostumus käytettäväksi terapeuttisten aineiden kantajana
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
FI880195A0 (fi) Terapeutiska produkter.
NZ219374A (en) Topical pharmaceutical containing tamoxifen
YU156788A (en) Process for producing matrix for releasing and/or dosing healing active material
DK34687A (da) Laegemiddel til nasal anvendelse, dets fremstilling og anvendelse
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
DE68921180D1 (de) Apparat für die Verabreichung von Medikamenten für die Veterinärmedizin.
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
AU637419B2 (en) Application of a carbothioamine 1-oxide to the preparation of medicinal products for the treatment of coronary insufficiency
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
DK0608648T3 (da) Højdoserede vitamin A-præparater
RU92015818A (ru) Способ для лечения энуреза
DK477388A (da) Laegemiddel indeholdende n-alkylscopolaminiumsalt_og nitroglycerin, fremgangsmaade til fremstilling deraf samt dets anvendelse
NO901688D0 (no) Soelvsulfadiazinholdig farmasoeytisk produkt for lokal ekstern terapi.
ATE87211T1 (de) Heilpflanzengemisch fuer die behandlung von depressionen.
ATE72981T1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
RO101804A2 (ro) Medicament lichid pentru terapie cu aerosoli
ATE88342T1 (de) Pharmazeutische zubereitungen zur behandlung der psoriasis, psoriatischen arthritis, neurodermitis und enteritis regionalis crohn.

Legal Events

Date Code Title Description
PUP Patent expired